Salute e Benessere

Combining EVP roles of Human Health Biosolutions and Strategy & Integration

As a next step on Novonesis' integration journey, we combine the two EVP areas Human Health Biosolutions and Strategy & Integration. COPENHAGEN, Denmark –After successfully combining into one company, Novonesis is delivering strong results, progressing firmly on the integration, as well as realizing synergies across the company. As a next step on our integration journey, the EVP area of Strategy & Integration will combine with the Human Health Biosolutions sales area. Henrik...

Transactions under Novonesis' share buyback program

Please read the announcement in PDF Attachment 2025_25_Share_buyback_program

Gradient Denervation Technologies Announces FDA Breakthrough Designation for…

The Gradient Denervation System is a novel technology intended to treat patients with pulmonary hypertension and associated heart failure. Treatment is accomplished by ablating nerves around the pulmonary artery using therapeutic ultrasound energy in a minimally invasive, percutaneous procedure. The straightforward catheter platform was designed specifically for the pulmonary artery anatomy and leverages known interventional techniques. The treatment goal is to down-regulate the sympathetic...

OKYO Pharma to Present at the GPCRs-Targeted Drug Discovery Summit

LONDON and NEW YORK, May19, 2025(GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain, a severe ocular condition without an FDA approved therapy, and for inflammatory eye diseases, announced that its CEO, Gary S. Jacob, Ph.D., will be giving an oral presentation at the 4 thAnnual GPCRs-Targeted Drug Discovery Summit in Boston, MA on May 22, 2025. Dr. Jacob's...

Trading in GN Store Nord shares by board members, executives and associated…

GN Store Nord has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in GN Store Nord made by persons discharging managerial responsibilities in GN Store Nord and/or persons closely associated with them. 1.Details of the person discharging managerial responsibilities/person closely associated NameJukka Pekka Pertola 2.Reason for the notification Position/statusChair of the Board of ...

Cell Impact delivers flow plates and test tools to a major player in Asia

"The tests of our forming technology conducted by this customer have been successful, which has laid the foundation for today's agreement. This is a process we have seen before. Successful tests of Cell Impact Forming™ lead to new business, which in turn is a prerequisite for future volume production," says Mr.Daniel Vallin, CEO of Cell Impact. The order includes both flow plates and a test tool that will be used to manufacture customized flow plates. Delivery will take place...

Teva Announces $2,000,000,000 (Equivalent) Debt Tender Offers For Notes Due…

Teva ”) announced today that it has commenced tender offers (the “ Offers ”) to purchase for cash for a combined aggregate purchase price (exclusive of accrued and unpaid interest) of up to $2,000,000,000 (equivalent) (the “ TotalMaximumAmount ”) of the following series of notes issued by finance subsidiaries of Teva and guaranteed by Teva: USD 3.150% Senior Notes due 2026, CUSIP 88167AAE1 / ISIN US88167AAE10 (Registered), issued by Teva Pharmaceutical Finance Netherlands III B.V...

Teva Announces Launch of $2,000,000,000 (Equivalent) Offering of Senior Notes

Teva ”) announced today its intention to issue $2,000,000,000 (equivalent) of senior notes through its special purpose finance subsidiaries. Teva Pharmaceutical Finance Netherlands II B.V. (“ Teva Finance II ”) intends to offer EUR-denominated Senior Notes (the “ EuroNotes ”) and Teva Pharmaceutical Finance Netherlands III B.V. (“ TevaFinanceIII ”) and Teva Pharmaceutical Finance Netherlands IV B.V. (“ Teva Finance IV ” and, together with Teva Finance II and Teva Finance III, the “...

Trading in GN Store Nord shares by board members, executives and associated…

GN Store Nord has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in GN Store Nord made by persons discharging managerial responsibilities in GN Store Nord and/or persons closely associated with them. 1.Details of the person discharging managerial responsibilities/person closely associated NameJørgen Bundgaard Hansen 2.Reason for the notification Position/statusMember of the Board of...

Philips launches real-time 3D intracardiac imaging in Europe, expanding access…

May 19, 2025VeriSight Pro 3D ICE catheter is a pioneering innovation — a miniaturized ultrasound probe embedded at the tip of a thin, steerable catheter, navigated through the vascular system into the heart chambers to deliver high-quality 2D and 3D images in real timeCatheter offers enhanced procedural guidance without the need for general anesthesia, supporting more efficient and patient-friendly care for structural heart diseaseAmsterdam, the Netherlands –Royal Philips...

Alvotech Appoints DNB Carnegie as Liquidity Provider on Nasdaq Stockholm

REYKJAVIK, ICELAND AND STOCKHOLM, SWEDEN (May 19, 2025)— Alvotech (NASDAQ: ALVO, the “Company”) has entered into agreement with DNB Carnegie Investment Bank AB (publ) (“DNB Carnegie”) regarding liquidity provider services to ensure liquidity in the Company's Swedish Depository Receipts (“SDRs”), equity share equivalents, trading on Nasdaq Stockholm. The arrangement is in accordance with the framework of Nasdaq Stockholm's rules on liquidity providers.In the role of liquidity provider,...

SIFI receives Marketing Authorisation and Promising Innovative Medicine…

A few days before, the MHRA also awarded AKANTIOR the Promising Innovative Medicine (PIM) designation, confirming that AKANTIOR® meets all three of the following criteria established by the MHRA: A few days before, the MHRA also awarded AKANTIOR thePromising Innovative Medicine (PIM)designation, confirming that AKANTIOR® meets all three of the following criteria established by the MHRA: AKANTIOR®becomes thefirst and only approved treatmentforAcanthamoeba keratitisin the...

Trading in Alvotech's Shares on Nasdaq Stockholm Commences Today

Not to be released, published, distributed or circulated in any jurisdiction in which it would be unlawful to do so. This press release is for information purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities. REYKJAVIK, ICELAND AND STOCKHOLM, SWEDEN (May 19, 2025)— On May 16, 2025 Alvotech (NASDAQ: ALVO, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients...

LIfT BioSciences presents latest data on its first-in-class Immunomodulatory…

LIfT BioSciences presents latest data on its first-in-class Immunomodulatory Alpha Neutrophils at International Society for Cell and Gene Therapy London,19 May 2025– LIfT BioSciences, ('LIfT' or 'the Company'), a rapidly emerging biotech and the global leader in neutrophil immunotherapies, today announces that preclinical data showing the potential of its first-in-class Immunomodulatory Alpha Neutrophils (IMANs) as a disruptive new class of immunotherapy for solid tumours was presented...

AB Science receives Chinese patent protecting masitinib in the treatment of…

PRESS RELEASE AB SCIENCE RECEIVES CHINESE PATENT PROTECTING MASITINIB IN THE TREATMENT OF COVID-19 UNTIL 2041, ADDING ONE MORE INDICATION WITH LONG TERM INTELLECTUAL PROPERTY PROTECTIONParis, May 19, 2025, 8am CETAB Science SA(Euronext - FR0010557264 - AB) today announced that the Chinese Patent Office has issued a patent relating to methods of treating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causing COVID-19 (i.e. a medical use patent) with its...

Innovations in High Blood Pressure Intervention Benefit Patients with Resistant…

According to a report from the World Health Organization, the number of adults with hypertension doubled between 1990 and 2019 from 650 million to 1.3 billion. The report also states that only 54 percent of adults with hypertension are diagnosed and only 42 percent receive treatment. And recent studies1,2 have suggested that BP assessment in the clinical setting can often get a hypertension diagnosis wrong or miss it completely. Left undetected or uncontrolled, hypertension is a leading…

Alvotech Announces the Outcome of the Offering in Connection with the Company's…

Not to be released, published, distributed or circulated in any jurisdiction in which it would be unlawful to do so. This press release is for information purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities. REYKJAVIK, ICELAND AND STOCKHOLM, SWEDEN (May 16, 2025)— Alvotech (NASDAQ: ALVO, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today...

New Healthcare AI Models Could Reshape Everything From Burnout to Diagnostics

VANCOUVER, BC, May 16, 2025 /PRNewswire/ -- Equity InsiderNews Commentary – AI is no longer just assisting healthcare — it's beginning to rewire it from the ground up. From streamlining diagnostics and automating clinical documentation to predicting disease and optimizing hospital operations, generative AI is now touching every layer of the care continuum. As policymakers in places like Connecticut debate how to regulate this growing influence, and initiatives like OpenAI's HealthBench push the…

MIT, University of Colorado Denver, and Clue App Publish Largest Women's Health…

Analysis of 2.2 million menstrual cycles tracked in Clue shows connection between pollution exposure and reproductive health Senseable City Lab and the University of Colorado Denver , in collaboration with the Clue app, have published the largest study of its kind examining the impact of air pollution on menstrual health across multiple countries. The research, just published inThe Lancet Planetary Health, analyzed data from 2.2 million menstrual cycles tracked in Clue,...

Hisense Shines at Cannes as Named Partner of CHINA NIGHT

Later, at the wine reception, guests enjoyed perfectly chilled vintages from the ASKO Wine Climate Cabinet. With three independent temperature zones, wooden shelves for up to 190 bottles, UV-filtered glass, soft LED shelf lighting, and an RGB-lit serving area, it delivered both function and style. Integrated Vivino support allowed guests to browse and select wines directly from the cabinet's interface. Meanwhile, the C2 Ultra TriChroma Laser Mini Projector delivered 4K visuals at 3,000 ANSI…

Live Cell Imaging Market Skyrockets to $4.49 billion by 2030 Dominated by…

Integration of High-Content Imaging with Cell-Based Research and Biomanufacturing Workflows Enhances Demand for Live Cell Imaging: Integration of High-Content Imaging with Cell-Based Research and Biomanufacturing Workflows Enhances Demand for Live Cell Imaging: Live cell imaging has transitioned from specialized research equipment to become fundamental in cell biology research while supporting therapeutic development and regenerative medicine advancement. As outlined in the Cell...

Transactions of Managers and Closely Associated Persons

Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the acquisition of 19,988 shares in Alvotech at USD 10.18 per share, by Richard Davies, Deputy Chairman of the Board of Directors Alvotech. The transaction is dated May 14, 2025. Attachment Managers Transaction-CSSF Form - Richard Davies 2025-05-16

Magstim Granted EU MDR Certification

Magstim Passes Compliance with Strict European Union Medical Device Regulations Expanding Magstim Access to Entire EU MarketplaceWHITLAND, United Kingdom, May16, 2025(GLOBE NEWSWIRE) -- Magstim has been granted EU MDR Certification for all transcranial magnetic stimulation (TMS) systems, demonstrating compliance with strict European Union Medical Device Regulations. This provides a path for Magstim TMS technology to be sold throughout the EU marketplace, and proves that the device is...

CathWorks Announces Key Events for EuroPCR 2025

Educational Symposium Educational Symposium The FFRangio System will be available for hands-on demonstrations and peer-to-peer education during Meet the Expert sessions hosted by leading physicians in the Medtronic booth. "Our co-promotion partnership with Medtronic has enabled the rapid growth in adoption and seamless integration of the FFRangio System in hundreds of catheterization labs around the globe. We are excited about the prominent presence of FFRangio at EuroPCR and we look...

Altri Comunicati